BSE filing, NSE: OSIAJEE. Summary written from the filing by ALFA Finder's alert engine.
Osiajee Texfab Ltd: key numbers
- Share price
- ₹199.95
- Market cap
- ₹108.0 Cr
- Revenue (annual)
- ₹6.49 Cr
- Net profit (annual)
- ₹5.55 Cr
- P/E (TTM)
- 19.6×Sector 49.5×
- Promoter holding
- 2.78%+0.00% QoQ
- FII holding
- 13.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Osiajee Texfab Ltd
All →Osiajee Texfab Stock Split
Osiajee Texfab Ltd shareholders approved a 1:10 stock split at their Annual General Meeting. Each Rs.10 face value share will be sub-divided into ten Rs.1 shares.
Osiajee Texfab Annual General Meeting
Osiajee Texfab Limited held its 31st Annual General Meeting on September 29, 2026, considering financial statements, various appointments, and a proposed stock split of equity shares.
Osiajee Texfab Annual General Meeting
Osiajee Texfab Ltd has scheduled its 31st Annual General Meeting for September 29, 2026, via video conferencing. The company also published its Annual Report for 2025-26.
Osiajee Texfab Management Change
Osiajee Texfab Limited announced the appointment of three new Independent Directors and the resignation of three existing Independent Directors. The board also reconstituted its core committees.
Osiajee Texfab Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 25.0% YoY
Osiajee Texfab Ltd reported revenue from operations of ₹0.7 Cr (-12.5% YoY) and net profit of ₹0.3 Cr (-25.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · -25.0% YoY
Osiajee Texfab Board Meeting Date
Osiajee Texfab Limited will hold a Board Meeting on August 13, 2026. The meeting will discuss quarterly financial results and a proposed stock split.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.